<--- Back to Details
First PageDocument Content
Health / Pharmaceutical sciences / Pharmacy in the United Kingdom / Executive agencies of the United Kingdom government / Veterinary Medicines Directorate / Clinical pharmacology / Pharmaceuticals policy / European Medicines Agency / National Office of Animal Health / Good laboratory practice / Summary of Product Characteristics / Paraveterinary workers
Date: 2016-04-25 10:46:34
Health
Pharmaceutical sciences
Pharmacy in the United Kingdom
Executive agencies of the United Kingdom government
Veterinary Medicines Directorate
Clinical pharmacology
Pharmaceuticals policy
European Medicines Agency
National Office of Animal Health
Good laboratory practice
Summary of Product Characteristics
Paraveterinary workers

Code of Practice for the Promotion of Animal Medicines Together with the Rules of Procedure for the

Add to Reading List

Source URL: www.noah.co.uk

Download Document from Source Website

File Size: 577,69 KB

Share Document on Facebook

Similar Documents

Cell Therapy Catapult and MHRA co-operative working proposal  1 Introduction

Cell Therapy Catapult and MHRA co-operative working proposal 1 Introduction

DocID: 1qIdF - View Document

Code of Practice for the Promotion of Animal Medicines Together with the Rules of Procedure for the

Code of Practice for the Promotion of Animal Medicines Together with the Rules of Procedure for the

DocID: 1q2Fu - View Document

DocID: 1pJS9 - View Document

Moein Moghimi, PhD Professor and Chair in Pharmaceutics, School of Medicine, Pharmacy and Health, Durham University (United Kingdom) Moein is the Professor of Pharmaceutics at Durham University (UK). He is also a full af

Moein Moghimi, PhD Professor and Chair in Pharmaceutics, School of Medicine, Pharmacy and Health, Durham University (United Kingdom) Moein is the Professor of Pharmaceutics at Durham University (UK). He is also a full af

DocID: 1pJtA - View Document

JOINT SHOT MHRA STATEMENT THE DEVELOPMENT OF A JOINT UK HAEMOVIGILANCE SYSTEM The Medicines and Healthcare products Regulatory Agency (MHRA) and Serious Hazards of Transfusion (SHOT) teams have been working towards produ

JOINT SHOT MHRA STATEMENT THE DEVELOPMENT OF A JOINT UK HAEMOVIGILANCE SYSTEM The Medicines and Healthcare products Regulatory Agency (MHRA) and Serious Hazards of Transfusion (SHOT) teams have been working towards produ

DocID: 1pBJh - View Document